In vitro models to determine the pharmacokinetic parameters

Belma Pehlivanović



The pharmaceutical industry seeks to more efficient and precise determination of the main pharmacokinetic parameters of existing and new drugs, and therefor uses new in vitro models that show a high degree of correlation with in vivo response.

Determination of intestinal absorption, metabolic transformations and metabolic profile of drugs is carried out using the laboratory in vitro models, which represent innovative basis for determination of absorption, distribution, metabolism and elimination (ADME) of drugs .

The aim of this paper is to present three most important in vitro models, their properties and applications in the pharmaceutical industry when determining the pharmacokinetic parameters.

The rapid development of the pharmaceutical industry expressed the need for in vitro models for the determination of pharmacokinetic parameters in the laboratories that want to increase their operational efficiency and effectiveness.

Keywords: pharmacokinetics, drugs, parameters, in vitro models

Full Text:



Hunter J, Jepson MA, Tsuruo T, Simmons NL, and Hirst


Functional expression of P-glycoprotein in apical membranes

of human intestinal caco-2 cells. kinetics of vinblastine

secretion and interaction with modulators. J Biol Chem

: 199, 14991-14997.

Cummins CL, Mangravite LM, and Benet LZ, Characterizing

the expression of CYP3A4 and efflux transporters

(P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2

cells after induction with sodium butyrate and the phorbol

ester 12-O-tetradecanoylphorbol-13-acetate. Pharm


Hidalgo IJ, Raub TJ, and Borchardt RT. Characterization

of the human colon carcinoma cell line (Caco-2) as a model

system for intestinal epithelial permeability. Gastroenterology

: 1989; 736-749.

Bermejo, M. et al. PAMPA – a drug absorption in vitro

model 7. Comparing rat in situ, Caco-2, and PAMPA permeability

of fluoroquinolones. Pharm. Sci., 21:2004; 429-

Avdeef, A. et al. Caco-2 permeability of weakly basic drugs

predicted with the Double-Sink PAMPA pKaflux method.

Pharm. Sci., 24:2005; 333-349

Shane C. Gad, Preclinical Development Handbook: ADME

and Biopharmaceutical properties, John Whiley and Sons

Inc, 2008.


  • There are currently no refbacks.